<code id='5C4DE6D923'></code><style id='5C4DE6D923'></style>
    • <acronym id='5C4DE6D923'></acronym>
      <center id='5C4DE6D923'><center id='5C4DE6D923'><tfoot id='5C4DE6D923'></tfoot></center><abbr id='5C4DE6D923'><dir id='5C4DE6D923'><tfoot id='5C4DE6D923'></tfoot><noframes id='5C4DE6D923'>

    • <optgroup id='5C4DE6D923'><strike id='5C4DE6D923'><sup id='5C4DE6D923'></sup></strike><code id='5C4DE6D923'></code></optgroup>
        1. <b id='5C4DE6D923'><label id='5C4DE6D923'><select id='5C4DE6D923'><dt id='5C4DE6D923'><span id='5C4DE6D923'></span></dt></select></label></b><u id='5C4DE6D923'></u>
          <i id='5C4DE6D923'><strike id='5C4DE6D923'><tt id='5C4DE6D923'><pre id='5C4DE6D923'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:1
          Bristol Myers Squibb sign
          Courtesy Bristol Myers Squibb

          Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

          RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

          advertisement

          Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more
          Biden warns of ‘dark winter’ during final presidental debate
          Biden warns of ‘dark winter’ during final presidental debate

          DemocraticpresidentialcandidateformerVicePresidentJoeBidenanswersaquestionasPresidentTrumplistensdur

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          New research casts further doubt on a common procedure used with IVF

          AdobeAcommoninvitrofertilizationprocedureofferedtopatientswiththepromiseofincreasingtheirlikelihoodo